Medical researchers have published correspondence in The Lancet raising concerns about a recent study on anti-inflammatory reliever (AIR) therapy for children with mild asthma. The correspondence addresses unanswered questions regarding the CARE study, which compared AIR therapy to salbutamol treatment in school-age children and adolescents.
The CARE study examined AIR therapy as an alternative treatment approach for mild asthma in younger patients. The correspondence suggests that despite the study's publication, significant questions remain about this therapeutic strategy and its application in pediatric populations.